Key result
A pulmonary end diameter > 2.5 mm from the suprasternal view strongly predicted the likelihood of patent ductus arteriosus device closure over coil closure (AUC 0.971).
Why the study?
What are the echocardiographic predictors for choosing device versus coil closure in patients undergoing percutaneous patent ductus arteriosus closure?
Observational (n=76)
What are the echocardiographic predictors for choosing device versus coil closure in patients undergoing percutaneous patent ductus arteriosus closure?
Echocardiographic measurements, particularly a pulmonary end diameter > 2.5 mm, can accurately predict the need for device rather than coil closure for patent ductus arteriosus.
Answers are grounded in this paper and cite their sources.
May guide device selection in PDA closure; leaves open prospective validation before practice change.
AIM: To determine anatomic and hemodynamic echocardiographic predictors for patent ductus arteriosus (PDA) device vs coil closure. METHODS: Seventy-six patients who were referred for elective transcatheter PDA closure were enrolled in the study. All patients underwent full echocardiogram including measurement of the PDA pulmonary end diameter, color flow width and extent, peak and end-diastolic Doppler gradients across the duct, diastolic flow reversal, left atrial dimensions and volume, left ventricular sphericity index, and volumes. RESULTS: The study group was subdivided into 2 subgroups based on the mode of PDA closure whether by coil (n = 42) or device (n = 34). Using univariate analysis there was a highly significant difference between the 2 groups as regard the pulmonary end diameter measured in both the suprasternal and parasternal short-axis views as well as the color flow width and color flow extent (P < .0001). The device closure group had statistically significant higher end-systolic and end-diastolic volumes indexed, left atrial volume, and diastolic flow reversal. Receiver operating characteristic curve analysis showed a pulmonary end diameter cutoff point from the suprasternal view > 2.5 mm and from parasternal short-axis view > 2.61 mm to have the highest balanced sensitivity and specificity to predict the likelihood for device closure (AUC 0.971 and 0.979 respectively). The pulmonary end diameter measured from the suprasternal view was the most independent predictor of device closure. CONCLUSION: The selection between PDA coil or device closure can be done on the basis of multiple anatomic and hemodynamic echocardiographic variables.
No takes yet. Share an insight, caveat, or question.
Roushdy et al. (2017) conducted an observational in Patent ductus arteriosus (PDA) (n=76). Device closure vs. Coil closure was evaluated on Likelihood for device closure based on pulmonary end diameter from suprasternal view > 2.5 mm (AUC 0.971, p=< .0001). A pulmonary end diameter > 2.5 mm from the suprasternal view strongly predicted the likelihood of patent ductus arteriosus device closure over coil closure (AUC 0.971).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: